The stock of Agilon Health Inc (AGL) has gone up by 3.13% for the week, with a -40.43% drop in the past month and a -31.79% drop in the past quarter. The volatility ratio for the week is 6.70%, and the volatility levels for the past 30 days are 7.24% for AGL. The simple moving average for the last 20 days is -22.86% for AGL stock, with a simple moving average of -43.42% for the last 200 days.

Is It Worth Investing in Agilon Health Inc (NYSE: AGL) Right Now?

Moreover, the 36-month beta value for AGL is 0.59. Analysts have varying opinions on the stock, with 14 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"


The average price recommended by analysts for Agilon Health Inc (AGL) is $22.31, which is $10.79 above the current market price. The public float for AGL is 300.13M and currently, short sellers hold a 15.45% of that float. On November 21, 2023, AGL’s average trading volume was 2.68M shares.

AGL) stock’s latest price update

The stock price of Agilon Health Inc (NYSE: AGL) has plunged by -3.52 when compared to previous closing price of 11.94, but the company has seen a 3.13% gain in its stock price over the last five trading sessions. Seeking Alpha reported 2023-11-20 that agilon health’s full-year outlook caused its stock to fall sharply, raising concerns about the sustainability of its business model. While the company reported a 71% increase in revenue and a rise in Medicare Advantage membership, its gross profit growth doesn’t hold up. A $5 billion market cap appears too high, considering agilon’s low medical margins.

Analysts’ Opinion of AGL

Many brokerage firms have already submitted their reports for AGL stocks, with The Benchmark Company repeating the rating for AGL by listing it as a “Buy.” The predicted price for AGL in the upcoming period, according to The Benchmark Company is $28 based on the research report published on October 20, 2023 of the current year 2023.

AGL Trading at -32.42% from the 50-Day Moving Average

After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.87% of loss for the given period.

Volatility was left at 7.24%, however, over the last 30 days, the volatility rate increased by 6.70%, as shares sank -38.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -37.83% lower at present.

During the last 5 trading sessions, AGL rose by +3.13%, which changed the moving average for the period of 200-days by -47.76% in comparison to the 20-day moving average, which settled at $14.57. In addition, Agilon Health Inc saw -28.62% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at AGL starting from Shaker Benjamin, who sale 18,750 shares at the price of $18.00 back on Sep 13. After this action, Shaker Benjamin now owns 79,543 shares of Agilon Health Inc, valued at $337,455 using the latest closing price.

Shaker Benjamin, the Chief Markets Officer of Agilon Health Inc, sale 18,750 shares at $18.05 during a trade that took place back on Sep 12, which means that Shaker Benjamin is holding 79,543 shares at $338,481 based on the most recent closing price.

Stock Fundamentals for AGL

Current profitability levels for the company are sitting at:

The net margin for Agilon Health Inc stands at -3.95. The total capital return value is set at -10.49, while invested capital returns managed to touch -9.59. Equity return is now at value -9.05, with -4.27 for asset returns.

Based on Agilon Health Inc (AGL), the company’s capital structure generated 5.48 points at debt to equity in total, while total debt to capital is 5.20. Total debt to assets is 3.36, with long-term debt to equity ratio resting at 4.65. Finally, the long-term debt to capital ratio is 4.40.

When we switch over and look at the enterprise to sales, we see a ratio of 0.95, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 6.85 and the total asset turnover is 1.65. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.71.


To wrap up, the performance of Agilon Health Inc (AGL) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.